发明名称 A process for the enantiospecific synthesis of intermediates for hexahydro-benzo¬d naphto¬2,1-b azepines
摘要 <p>Biologically active, enantiomerically substantially pure intermediates of trans-hexahydro-benzo[d]naphtho[2,1-b] azepines are prepared. The present invention involves a process for preparing compounds of the general formula 3: &lt;CHEM&gt; Each R&lt;1&gt; is independently H or alkyl; Q is methylene, -O- or -S-; m and n are independently variable and may each have a value of 0, 1 or 2 with the provisos that the sum of m and n is not greater than 3, that m may not equal zero when Q is -O- or -S-, and that when Q is -CH2-, m and n cannot both be zero; X is hydrogen, halo, alkyl, alkylthio, alkylsulfinyl, alkylsufonyl, hydroxy, alkoxy or trifluoromethyl; Y is hydrogen, hydroxy, alkoxy, -OC(O)NR&lt;2&gt;R&lt;3&gt;, -OC(O)-R&lt;9&gt;, -N(R&lt;1&gt;)2, -NHC(O)R&lt;1&gt; or -OP(O)(OH)OR&lt;1&gt;; R&lt;2&gt; and R&lt;3&gt; are the same or different and each is hydrogen (provided that both are not hydrogen), alkyl, aralkyl, cycloalkyl, aryl, hydroxyalkyl, or alkoxyalkyl; in addition, when one of R&lt;2&gt; and R&lt;3&gt; is as defined above, the other may be -R&lt;4&gt;NR&lt;5&gt;R&lt;6&gt; {wherein R&lt;4&gt; is alkanediyl, R&lt;5&gt; is hydrogen or alkyl and R&lt;6&gt; is alkyl, or R&lt;5&gt; and R&lt;6&gt; together with the nitrogen atom form a 1-azetidinyl, 1-pyrrolidinyl, 1-piperidinyl, 1-(4-alkylpiperazinyl), 4-morpholinyl or 1-(hexahydroazepinyl) group}; in further addition, R&lt;2&gt; and R&lt;3&gt; together with the nitrogen atom may form a 1-azetidinyl, 1-pyrrolidinyl, 1-piperidinyl, 4-morpholinyl, 1-(4-alkylpiperazinyl), 1-(4-alkoxyalkylpiperazinyl), 1-(4-hydroxyalkylpiperazinyl), 1-(3-hydroxyazetidinyl), 1-(3-alkoxyazetidinyl), 1-(-hydroxypyrrolidinyl), 1-(3-alkoxypyrrolidinyl), 1-(3- or 4-hydroxypiperidinyl), 1-(3- or 4-alkoxypiperidinyl), 1-(4-oxopiperidinyl) or 1-(3-oxopyrrolidinyl) ring; in still further addition, when R&lt;2&gt; is hydrogen, R&lt;3&gt; may be -CHR&lt;7&gt;CO2R&lt;8&gt;, wherein R&lt;7&gt; and R&lt;8&gt; are the same or different and each is hydrogen, alkyl or aralkyl; R&lt;9&gt; is alkyl, aralkyl, aryl, alkoxyalkyl, aryloxyalkyl, aralkoxyalkyl, cycloalkylalkyl, alkoxycarbonylalkyl, cycloalkyl, 1-adamantyl, cycloalkoxyalkyl, alkoxy, aralkyloxy, cycloalkoxy, aryloxy or -CHR&lt;7&gt;NHR&lt;8&gt; ; and Z is X as defined above, amino, alkylamino or -NHC(O)R&lt;1&gt;&lt;0&gt; {wherein R&lt;1&gt;&lt;0&gt; is hydrogen, alkyl or aryl}; R&lt;1&gt;&lt;1&gt; is H or alkyl; R&lt;1&gt;&lt;2&gt; is alkyl; with the proviso that R&lt;1&gt;&lt;1&gt; and R&lt;1&gt;&lt;2&gt; are different, and K is hydrogen, alkoxy, hydroxyl, arloxy or alkyl.</p>
申请公布号 EP0354686(A1) 申请公布日期 1990.02.14
申请号 EP19890307649 申请日期 1989.07.27
申请人 SCHERING CORPORATION 发明人 BERGER, JOEL GILBERT;CLADER, JOHN WELCH
分类号 C07D223/16;C07B61/00;C07C209/00;C07C209/24;C07C209/28;C07C209/70;C07C211/42;C07C211/45;C07C211/50;C07C211/57;C07C213/08;C07C217/74;C07D223/14 主分类号 C07D223/16
代理机构 代理人
主权项
地址
您可能感兴趣的专利